TownSquare Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,046
Closed -$110K 1062
2023
Q1
$110K Buy
12,046
+298
+3% +$3.81K ﹤0.01% 935
2022
Q4
$134K Buy
11,748
+1,552
+15% +$23K ﹤0.01% 892
2022
Q3
$174K Sell
10,196
-166
-2% -$3.56K 0.01% 708
2022
Q2
$223K Sell
10,362
-1,648
-14% -$45.7K 0.01% 629
2022
Q1
$444K Buy
+12,010
New +$468K 0.01% 518
2021
Q4
Sell
-5,940
Closed -$376K 718
2021
Q3
$376K Buy
+5,940
New +$452K 0.01% 507

Other funds holding CDNA

TownSquare Capital's CDNA Position: Q2 2023 in Review

TownSquare Capital sold out of CareDx (CDNA) in Q2 2023, closing a stake of 12,046 shares — an estimated $110K sold.

TownSquare Capital first reported a position in CDNA in Q3 2021 and held it in 6 quarters. The position peaked at $444K in Q1 2022. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2023.

  • TownSquare Capital reported no remaining CareDx position as of Q2 2023 after selling out during the quarter.
  • TownSquare Capital sold 12,046 CareDx shares in Q2 2023, an estimated $110K.
  • TownSquare Capital first reported a position in CareDx in Q3 2021 and held it in 6 quarters.
  • TownSquare Capital's CareDx position peaked at $444K in Q1 2022.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2023.

Based on TownSquare Capital's 13F filing for Q2 2023, filed 13 Nov 2023.